The dose depends on whats in it
PREG and ALLO have been investigated as potential therapeutics for treating memory deficits associated with schizophrenia (65, 238)
(7) These are observational cohorts with their own populations, confounders, and limits, so the numbers describe an association in a group, not a prediction for an individual
Mechanisms behind its fat-loss potential: Enhanced GH-induced lipolysis Preservation of lean tissue in a calorie deficit Increased metabolic rate via improved thyroid conversion and mitochondrial efficiency Improved insulin sensitivity in controlled dosages and healthy individuals Growth hormone secretagogues, including MK-677, have been shown to reduce visceral adiposity while preserving lean mass in hypocaloric states. Smith et al., Clinical Endocrinology 4
CJC-1295 without DAC (Modified GRF 1-29) is a modified version with substitutions that resist enzymatic degradation, extending the half-life to about 30 minutes